Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New stimulation device aims to boost recovery after brain and spinal injuries

NCT ID NCT07396922

First seen Feb 15, 2026 · Last updated Jun 22, 2026 · Updated 27 times

Summary

This study tests a new device called SSMD that uses gentle electrical stimulation to help people recover movement after a stroke, traumatic brain injury, spinal cord injury, or nerve damage. About 120 adults with moderate to severe arm or leg weakness will receive either the SSMD device or standard functional electrical stimulation, plus usual therapy, for 3 weeks. The main goal is to see if the SSMD device improves arm function better than the standard approach.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Polsko-Amerykańskie Kliniki Serca SA, Uzdrowisko Ustroń

    Ustroń, 43-450, Poland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

SSMD device (non-invasive electrical stimulation)

What this could lead to

If successful, this device could offer a new, non-invasive way to improve arm and hand function during rehabilitation after neurological injuries.

What could go wrong

This is an early-stage study with only 120 participants and a short 3-week treatment period. The device may not prove more effective than existing therapies like functional electrical stimulation.

Conditions

The condition(s) this trial relates to.

multiple sclerosis neuritis peripheral neuropathy spinal cord injury stroke disorder traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.